A Novel <scp>3D</scp> ‐Printed Strut‐Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid‐Term Follow‐Up Outcome

ABSTRACT Background Parosteal osteosarcoma (PAOS) is a rare and low‐grade primary bone malignant tumor that typically occurs in the distal femur. Traditional reconstruction options for distal femur PAOS include distal femoral replacement (DFR), autografts, and allografts, but issues such as functional sacrifice, insufficient mechanical strength, and low bone union rate limit their further clinical application. 3D‐printed prosthesis, due to the matching shape of various bone defects, could be a novel strategy to reconstruct the hemicortical defect after distal femur PAOS tumor resection. In this study, we designed a 3D‐printed strut‐type prosthesis (3DPSP) to repair the hemicortical defect and evaluated the mid‐term effect in distal femur PAOS. Methods A retrospective analysis was conducted on patients diagnosed with PAOS at the distal femur between April 2018 and January 2021. Six patients received DFR and six patients received customized 3DPSP reconstruction. Clinical outcomes including oncology status, defect lengths, and ranges of motion of the knee, Musculoskeletal Tumor Society (MSTS) scores, and complications were recorded. X‐ray was performed to evaluate the position and stability of the prosthesis and T‐SMART was applied to assess the interface osteointegration between prosthesis and bone. Results A total of 12 patients were enrolled in this study with an average follow‐up of 42.1 ± 11.8 months, ranging from 22 to 59 months. In the 3DPSP group, the average operation time was 2.3 ± 0.4 h; the intraoperative blood loss was 175.0 ± 82.2 mL. The average range of motion of the knee was 0°–123° and the mean MSTS score was 28.3 ± 1.6. Compared to the DFR group, the 3DPSP group exhibited significantly less intraoperative blood loss and superior functional recovery. Conclusions In this study, we designed a novel 3DPSP to reconstruct the hemicortical defect after distal femur PAOS resection. The mid‐term follow‐up result demonstrated that this prosthesis could be an effective reconstruction option for distal femur PAOS patients because of the restored limb function and favorable bone‐prosthesis integration. Further observation of this novel prosthesis is needed.

Authors

Institutions

Publication Details

Journal
Orthopaedic Surgery
Published
2026-06-18
DOI
https://doi.org/10.1111/os.70360
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel 3D ‐Printed Strut‐Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid‐Term Follow‐Up Outcome

Jianhua Mu, Chongqi Tu, H L Liu, Minxun Lu et al.
Orthopaedic Surgery
Sarcoma Diagnosis and Treatment
article

A Novel 3D ‐Printed Strut‐Type Prosthesis Reconstructs the Hemicortical Defect After Distal Femur Parosteal Osteosarcoma Resection: The Mid‐Term Follow‐Up Outcome

Jianhua Mu, Chongqi Tu, H L Liu, Minxun Lu, M Li, Zhuangzhuang Li, Xuanhong He, Yi Luo, Yong Zhou, Yuxing Wang, Fan Tang
article en

Abstract

ABSTRACT Background Parosteal osteosarcoma (PAOS) is a rare and low‐grade primary bone malignant tumor that typically occurs in the distal femur. Traditional reconstruction options for distal femur PAOS include distal femoral replacement (DFR), autografts, and allografts, but issues such as functional sacrifice, insufficient mechanical strength, and low bone union rate limit their further clinical application. 3D‐printed prosthesis, due to the matching shape of various bone defects, could be a novel strategy to reconstruct the hemicortical defect after distal femur PAOS tumor resection. In this study, we designed a 3D‐printed strut‐type prosthesis (3DPSP) to repair the hemicortical defect and evaluated the mid‐term effect in distal femur PAOS. Methods A retrospective analysis was conducted on patients diagnosed with PAOS at the distal femur between April 2018 and January 2021. Six patients received DFR and six patients received customized 3DPSP reconstruction. Clinical outcomes including oncology status, defect lengths, and ranges of motion of the knee, Musculoskeletal Tumor Society (MSTS) scores, and complications were recorded. X‐ray was performed to evaluate the position and stability of the prosthesis and T‐SMART was applied to assess the interface osteointegration between prosthesis and bone. Results A total of 12 patients were enrolled in this study with an average follow‐up of 42.1 ± 11.8 months, ranging from 22 to 59 months. In the 3DPSP group, the average operation time was 2.3 ± 0.4 h; the intraoperative blood loss was 175.0 ± 82.2 mL. The average range of motion of the knee was 0°–123° and the mean MSTS score was 28.3 ± 1.6. Compared to the DFR group, the 3DPSP group exhibited significantly less intraoperative blood loss and superior functional recovery. Conclusions In this study, we designed a novel 3DPSP to reconstruct the hemicortical defect after distal femur PAOS resection. The mid‐term follow‐up result demonstrated that this prosthesis could be an effective reconstruction option for distal femur PAOS patients because of the restored limb function and favorable bone‐prosthesis integration. Further observation of this novel prosthesis is needed.

Orthopaedic Surgery
Sichuan University (CN), West China Medical Center of Sichuan University (CN), West China Hospital of Sichuan University (CN)
Openalex Percentile: Top 7%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.